We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+10.65%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$63.8B
AUM Growth
+$3.93B
(+6.6%)
Cap. Flow
-$1.01B
Cap. Flow
% of AUM
-1.58%
Top 10 Holdings %
Top 10 Hldgs %
22.75%
Holding
3,125
New
60
Increased
388
Reduced
2,521
Closed
139
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Match Group
MTCH
|
+$20M |
| 2 |
iShares Core US Aggregate Bond ETF
AGG
|
+$11.8M |
| 3 |
Thermo Fisher Scientific
TMO
|
+$11.8M |
| 4 |
Caesars Entertainment
CZR
|
+$11.1M |
| 5 |
PROG Holdings
PRG
|
+$11M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$59.2M |
| 2 |
PPLI
People Inc
PPLI
|
+$24.6M |
| 3 |
CZR
Caesars Entertainment Corporation
CZR
|
+$19.1M |
| 4 |
Teradyne
TER
|
+$16.1M |
| 5 |
CTLT
CATALENT, INC.
CTLT
|
+$15.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.2% |
| 2 | Healthcare | 13.87% |
| 3 | Financials | 12.55% |
| 4 | Consumer Discretionary | 11.87% |
| 5 | Communication Services | 9.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1576
Howard Hughes
HHH
$4.03B
| $2.38M | ﹤0.01% |
43,357
-652
| -1% | -$34.8K |
|
1577
JELD-WEN Holding
JELD
$164M
| $2.38M | ﹤0.01% |
105,177
-18,470
| -15% | -$378K |
|
1578
S&T Bancorp
STBA
$1.79B
| $2.38M | ﹤0.01% |
134,364
-7,491
| -5% | -$156K |
|
1579
Agios Pharmaceuticals
AGIO
$1.93B
| $2.37M | ﹤0.01% |
67,654
-2,129
| -3% | -$93.3K |
|
1580
Perdoceo Education
PRDO
$2.12B
| $2.36M | ﹤0.01% |
192,997
-23,253
| -11% | -$338K |
|
1581
Benchmark Electronics
BHE
$2.96B
| $2.36M | ﹤0.01% |
117,073
-9,201
| -7% | -$187K |
|
|
HTO
1582
H2O America
HTO
$2.62B
| $2.36M | ﹤0.01% |
38,758
-5,832
| -13% | -$369K |
|
1583
Lantheus
LNTH
$6.59B
| $2.35M | ﹤0.01% |
185,884
-31,468
| -14% | -$432K |
|
1584
Laureate Education
LAUR
$5.28B
| $2.35M | ﹤0.01% |
177,284
-24,764
| -12% | -$297K |
|
1585
Brookfield Infrastructure
BIPC
$4.85B
| $2.35M | ﹤0.01% |
63,720
-12,686
| -17% | -$422K |
|
1586
Tompkins Financial
TMP
$1.42B
| $2.35M | ﹤0.01% |
41,410
-2,978
| -7% | -$189K |
|
|
TWOU
1587
DELISTED
2U Inc
TWOU
| $2.35M | ﹤0.01% |
2,313
+84
| +4% | +$99.9K |
|
1588
CorVel
CRVL
$3.19B
| $2.34M | ﹤0.01% |
82,170
-2,769
| -3% | -$74.3K |
|
1589
Opko Health
OPK
$1.02B
| $2.33M | ﹤0.01% |
630,748
-88,290
| -12% | -$373K |
|
1590
Cimpress
CMPR
$2.31B
| $2.33M | ﹤0.01% |
30,943
-5,200
| -14% | -$446K |
|
1591
Standex International
SXI
$4.12B
| $2.32M | ﹤0.01% |
39,244
-2,467
| -6% | -$142K |
|
|
UCTT
1592
Ultra Clean Holdings
UCTT
$3.95B
| $2.32M | ﹤0.01% |
108,125
-9,564
| -8% | -$232K |
|
1593
Rush Enterprises Class A
RUSHA
$6.22B
| $2.32M | ﹤0.01% |
103,187
-13,170
| -11% | -$280K |
|
|
FIT
1594
DELISTED
Fitbit, Inc. Class A common stock
FIT
| $2.31M | ﹤0.01% |
332,649
-58,490
| -15% | -$380K |
|
|
AIMT
1595
DELISTED
Aimmune Therapeutics
AIMT
| $2.31M | ﹤0.01% |
67,157
-22,170
| -25% | -$472K |
|
|
HSKA
1596
DELISTED
Heska Corp
HSKA
| $2.31M | ﹤0.01% |
23,412
-709
| -3% | -$70.1K |
|
1597
FB Financial Corp
FBK
$3.04B
| $2.31M | ﹤0.01% |
91,918
+61,261
| +200% | +$1.58M |
|
1598
Tanger
SKT
$4.52B
| $2.31M | ﹤0.01% |
382,506
-3,805
| -1% | -$23.9K |
|
|
ITCI
1599
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $2.29M | ﹤0.01% |
89,454
-11,303
| -11% | -$258K |
|
1600
Lakeland Financial Corp
LKFN
$1.53B
| $2.29M | ﹤0.01% |
55,500
-6,362
| -10% | -$288K |
|
Similar funds
VAM
RhumbLine Advisers's Q3 2020 Portfolio in Review
As of Q3 2020, RhumbLine Advisers held 3,125 positions worth $63.8B, up 6.6% from $59.9B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
RhumbLine Advisers's Q3 2020 filing shows 60 new, 388 increased, 2,521 reduced and 139 closed positions. Its largest new stake was PROG Holdings: 245,531 shares worth $11.8M. The largest sale was Apple, an estimated $59.2M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 23% a quarter earlier, followed by Healthcare and Financials.
- RhumbLine Advisers's largest Q3 2020 buy was PROG Holdings: 245,531 shares worth $11.8M.
- RhumbLine Advisers added most to Match Group in Q3 2020, an estimated $20M increase.
- RhumbLine Advisers's biggest Q3 2020 reduction was Apple, cutting an estimated $59.2M.
- RhumbLine Advisers fully exited Caesars Entertainment Corporation in Q3 2020, selling an estimated $19.1M.
- RhumbLine Advisers's ten largest holdings make up 23% of its $63.8B portfolio in Q3 2020.
- RhumbLine Advisers opened 60 new positions and closed 139 in Q3 2020.
- RhumbLine Advisers's portfolio value rose 6.6% quarter-over-quarter to $63.8B.
Based on RhumbLine Advisers's 13F filing for Q3 2020, filed 12 Nov 2020.